Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Cell Reports
|
November 1, 2018
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers
Hui Cheng, Xinping Yang, Han Si, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
Han Si, Michael Kuziora, Katie J Quinn, et al.
Genome Biology
|
October 9, 2013
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development
Yi-An Ko, Davoud Mohtat, Masako Suzuki, et al.
Circulation
|
April 22, 2009
Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension
Sebastian Brähler, Anuradha Kaistha, Volker J Schmidt, et al.
Circulation
|
August 27, 2003
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis
Ralf Köhler, Heike Wulff, Ines Eichler, et al.
Cancer Discovery
|
August 21, 2020
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade
Qu Zhang, Jia Luo, Song Wu, et al.
The Journal of Molecular Diagnostics : JMD
|
July 27, 2016
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods
Chih-Jian Lih, Han Si, Biswajit Das, et al.
Cancer Discovery
|
January 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
Ling Xie, Chunwei Xu, Han Si, et al.
Clinical and Translational Science
|
May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity
Marije B Overdijk, Kristin Strumane, Ruth Plummer, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Cell Reports
|
November 1, 2018
Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers
Hui Cheng, Xinping Yang, Han Si, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 23, 2020
A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study
Han Si, Michael Kuziora, Katie J Quinn, et al.
Genome Biology
|
October 9, 2013
Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development
Yi-An Ko, Davoud Mohtat, Masako Suzuki, et al.
Circulation
|
April 22, 2009
Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension
Sebastian Brähler, Anuradha Kaistha, Volker J Schmidt, et al.
Circulation
|
August 27, 2003
Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis
Ralf Köhler, Heike Wulff, Ines Eichler, et al.
Cancer Discovery
|
August 21, 2020
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade
Qu Zhang, Jia Luo, Song Wu, et al.
The Journal of Molecular Diagnostics : JMD
|
July 27, 2016
Certified DNA Reference Materials to Compare HER2 Gene Amplification Measurements Using Next-Generation Sequencing Methods
Chih-Jian Lih, Han Si, Biswajit Das, et al.
Cancer Discovery
|
January 20, 2026
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
Ling Xie, Chunwei Xu, Han Si, et al.
Clinical and Translational Science
|
May 23, 2026
Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity
Marije B Overdijk, Kristin Strumane, Ruth Plummer, et al.
Journal of Translational Medicine
|
November 6, 2019
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte, Sarah Warren, Jennifer Arrondeau, et al.
Page
of 8